Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ZIMLAB | NSE
3.09
4.80%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
02/04/2026
67.47
63.99
69.00
62.04
ZIM Laboratories Limited develops manufactures and supplies generic pharmaceutical and nutraceutical products in India and internationally. The company provides its products in pre- formulation intermediates and finished formulations using modified release patterns in the oral solid dosage forms such as granules pellets taste-masked powders suspensions tablets capsules dry syrup and oral thin films. It offers therapeutics in the areas of urology gastroenterology CNS antibiotics anti-infectives NSAIDs/pain analgesics and vitamins and supplements. ZIM Laboratories Limited was incorporated in 1984 and is based in Nagpur India.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
High Short-term Volatility
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
86.1%1 month
72.1%3 months
56.4%6 months
56.0%29.93
-
2.29
0.46
0.24
13.31
1.75
-
410.37M
3.29B
35.40M
-
3.78
260.00
21.30
7.86
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
9.69
Range1M
14.69
Range3M
22.04
Rel. volume
0.73
Price X volume
4.38M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Medico Remedies Limited | MEDICO | Drug Manufacturers-Specialty & Generic | 37.81 | 3.01B | -1.33% | 45.53 | 15.37% |
| Medicamen Biotech Limited | MEDICAMEQ | Drug Manufacturers-Specialty & Generic | 228.97 | 2.82B | -1.15% | 82.74 | 15.37% |
| Bafna Pharmaceuticals Limited | BAFNAPH | Drug Manufacturers-Specialty & Generic | 111.32 | 2.65B | -0.57% | 674.92 | 30.17% |
| Nectar Lifesciences Limited | NECLIFE | Drug Manufacturers-Specialty & Generic | 10.04 | 2.28B | 2.87% | 138.07 | 59.44% |
| Kilitch Drugs (India) Limited | KILITCH | Drug Manufacturers-Specialty & Generic | 138.65 | 2.24B | 0.22% | 42.44 | 17.95% |
| Lyka Labs Limited | LYKALABS | Biotechnology | 55.53 | 1.98B | 8.52% | 813.94 | 86.05% |
| Aarey Drugs & Pharmaceuticals Limited | AAREYDRUGS | Drug Manufacturers-Specialty & Generic | 53.71 | 1.56B | 0.81% | 32.75 | 23.61% |
| Brooks Laboratories Limited | BROOKS | Drug Manufacturers-Specialty & Generic | 53.38 | 1.42B | 19.87% | n/a | 8.60% |
| Alpa Laboratories Limited | ALPA | Drug Manufacturers-Specialty & Generic | 51.75 | 1.09B | 3.07% | 13.54 | 3.45% |
| Bal Pharma Limited | BALPHARMA | Drug Manufacturers-Specialty & Generic | 65.4 | 1.05B | 0.82% | 25.83 | 201.53% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Madhav Copper Limited | MCL | Copper | 60.36 | 1.67B | 4.99% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 84.36 | 1.23B | 0.67% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 66.71 | 743.74M | 1.24% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 22.45 | 389.73M | -1.92% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 6.97 | 152.71M | 0.72% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 13.31 | 24.85 | Cheaper |
| Ent. to Revenue | 1.75 | 11.40 | Cheaper |
| PE Ratio | 29.93 | 51.36 | Cheaper |
| Price to Book | 2.29 | 6.83 | Cheaper |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 56.43 | 42.17 | Riskier |
| Debt to Equity | 0.46 | 0.35 | Expensive |
| Debt to Assets | 0.24 | 0.17 | Expensive |
| Market Cap | 3.29B | 290.82B | Emerging |